NurExone Biologic announces annual general and special shareholder meeting

• NurExone Biologic will hold its annual general and special meeting in Toronto on Sept. 15, 2026.
• Shareholders will vote on a proposed share consolidation of up to 30 pre-consolidation shares for 1 post-consolidation share.
• Ballot items also include electing directors, reappointing the auditor, and reapproving the omnibus equity incentive plan.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NurExone Biologic Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608211603PRIMZONEFULLFEED9814345) on August 21, 2026, and is solely responsible for the information contained therein.